Azzad Asset Management’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-32,634
Closed -$548K – 346
2025
Q2
$548K Sell
32,634
-680
-2% -$9.19K 0.06% 266
2025
Q1
$426K Buy
+33,314
New +$535K 0.05% 274
2024
Q4
– Sell
-32,939
Closed -$753K – 261
2024
Q3
$753K Buy
32,939
+12,458
+61% +$281K 0.08% 246
2024
Q2
$470K Sell
20,481
-4,609
-18% -$142K 0.06% 268
2024
Q1
$994K Buy
25,090
+6,629
+36% +$262K 0.12% 217
2023
Q4
$730K Buy
18,461
+220
+1% +$9.21K 0.09% 242
2023
Q3
$809K Buy
18,241
+788
+5% +$34.4K 0.11% 226
2023
Q2
$759K Buy
17,453
+983
+6% +$43.2K 0.1% 243
2023
Q1
$717K Buy
16,470
+524
+3% +$23.1K 0.1% 238
2022
Q4
$595K Buy
15,946
+165
+1% +$6.38K 0.09% 244
2022
Q3
$628K Buy
15,781
+189
+1% +$7K 0.06% 322
2022
Q2
$597K Buy
15,592
+55
+0.4% +$1.99K 0.06% 327
2022
Q1
$616K Buy
+15,537
New +$608K 0.09% 264

Other funds holding NRC

Azzad Asset Management's NRC Position: Q3 2025 in Review

Azzad Asset Management sold out of NRC Health Common Stock (NRC) in Q3 2025, closing a stake of 32,634 shares — an estimated $548K sold.

Azzad Asset Management first reported a position in NRC in Q1 2022 and held it in 13 quarters. The position peaked at $994K in Q1 2024. 119 funds tracked by Wall St. Rank hold NRC as of Q3 2025.

  • Azzad Asset Management reported no remaining NRC Health Common Stock position as of Q3 2025 after selling out during the quarter.
  • Azzad Asset Management sold 32,634 NRC Health Common Stock shares in Q3 2025, an estimated $548K.
  • Azzad Asset Management first reported a position in NRC Health Common Stock in Q1 2022 and held it in 13 quarters.
  • Azzad Asset Management's NRC Health Common Stock position peaked at $994K in Q1 2024.
  • 119 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q3 2025.

Based on Azzad Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.